phosphoserine and neuropeptide y

phosphoserine has been researched along with neuropeptide y in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domin, H; Smiałowska, M; Wierońska, JM; Zieba, B1
Besik, V; Breit, A; Glas, E; Gudermann, T; Muehlich, S; Solinski, HJ; Yarwood, SJ1

Other Studies

2 other study(ies) available for phosphoserine and neuropeptide y

ArticleYear
The effect of intrahippocampal injection of group II and III metobotropic glutamate receptor agonists on anxiety; the role of neuropeptide Y.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:6

    Topics: Amino Acids, Dicarboxylic; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Autoradiography; Dose-Response Relationship, Drug; Hippocampus; In Situ Hybridization; Male; Microinjections; Neuropeptide Y; Phosphoserine; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; RNA, Messenger

2007
Serine-727 phosphorylation activates hypothalamic STAT-3 independently from tyrosine-705 phosphorylation.
    Molecular endocrinology (Baltimore, Md.), 2015, Volume: 29, Issue:3

    Topics: Animals; Bradykinin; Cell Line; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Genes, Reporter; Humans; Hypothalamus; Interferon-gamma; Ligands; Melanocyte-Stimulating Hormones; Mice; Neurons; Neuropeptide Y; Phosphorylation; Phosphoserine; Phosphotyrosine; Promoter Regions, Genetic; Receptors, Cytokine; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thyrotropin-Releasing Hormone; Transcriptional Activation

2015